首页> 美国卫生研究院文献>Journal of the Endocrine Society >Individualizing Management of Infertility in Classic Congenital Adrenal Hyperplasia and Testicular Adrenal Rest Tumors
【2h】

Individualizing Management of Infertility in Classic Congenital Adrenal Hyperplasia and Testicular Adrenal Rest Tumors

机译:经典先天性肾上腺皮质增生和睾丸肾上腺休息肿瘤的不育症的个体化管理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Testicular adrenal rest tumors (TARTs) are a common cause of male infertility in patients with classic congenital adrenal hyperplasia (CAH). These tumors are located in the rete testis and can lead to impaired blood flow and functional impairment of seminiferous tubules. We describe restoration of fertility in a man with CAH and bilateral TARTs with use of lower-dose glucocorticoid therapy than previously described. A 28-year-old man with classic salt-wasting CAH presented with impaired fertility. Biochemical evaluation showed poor CAH control despite reported compliance with prednisone 5 mg every morning and fludrocortisone 50 μg twice daily. Semen analysis showed azoospermia. Testicular ultrasonography showed TARTs occupying 16% of total testicular volume. After 5 months of dexamethasone 250 μg at bedtime, total TART volume decreased 90%, biochemical control improved, and semen analysis showed a sperm count of 132 × 10 million per milliliter. The patient’s wife was confirmed to be pregnant 9 months after the initial visit and delivered a healthy full-term baby girl. The patient’s glucocorticoid therapy was changed to prednisone 3 mg twice daily, and 2 years later he continues to show adequate CAH control, stable TART volume, and normal semen analysis, and his wife is pregnant again. Management of CAH in men with TARTs needs to be individualized, and high-dose dexamethasone may not be indicated. The use of a long-acting glucocorticoid at typical recommended dosages can decrease TART size and reverse male infertility. Prednisone given once daily does not adequately control the ACTH-driven complications of CAH.
机译:睾丸肾上腺休息肿瘤(TARTs)是经典先天性肾上腺皮质增生(CAH)患者男性不育的常见原因。这些肿瘤位于睾丸网,可能导致血流受损和曲细精管功能受损。我们描述了使用较低剂量的糖皮质激素治疗比先前描述的男性CAH和双侧TARTs恢复生育能力。一名患有经典食盐性CAH的28岁男子的生育能力受损。生化评估显示,尽管据报道每天早晨强的松5 mg和氟可的松50μg每天2次依从性,但CAH的控制仍较差。精液分析显示无精子症。睾丸超声检查显示,TART占睾丸总体积的16%。在就寝时间250克地塞米松5个月后,总TART量减少了90%,生化控制得到改善,精液分析显示每毫升精子数量为132×1000万。初诊9个月后,确认患者的妻子已怀孕,并已分娩出健康的足月女婴。患者的糖皮质激素治疗改为每天两次泼尼松3 mg,两年后,他继续表现出足够的CAH控制,稳定的TART量和精液分析正常,妻子再次怀孕。患有TART的男性中CAH的治疗需要个体化,并且可能不建议使用大剂量地塞米松。以典型推荐剂量使用长效糖皮质激素可减少TART大小并逆转男性不育症。每天一次泼尼松不能充分控制ACTH驱动的CAH并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号